#fatty liver disease

Two Experimental Therapies Show Promise for NASH

illustration of human body showing liver

11 Signs of Liver Disease

Regular Moderate Exercise Can Help Reduce Liver Fat

Two Experimental Therapies Show Promise for NASH

11 Signs of Liver Disease

Regular Moderate Exercise Can Help Reduce Liver Fat

NIH Awards $50.3 Million for “Multi-Omics” Research on Human Health and Disease

Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.

One Sugary Drink per Day May Increase Liver Cancer Risk in Women

About 63% of American adults consume at least one or more sugar-sweetened beverages daily.

Pecans May Help Prevent Fatty Liver Disease, Diabetes

In a mice study, daily consumption of pecans helped reduce inflammation and increase energy expenditure.

Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?

For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.

People With NASH Fare Worse Than Those With Diabetes

Advanced fatty liver disease led to a greater need for medical care and more difficulty with daily activities.

NASH Is Major Cause of Liver Cancer Among Transplant Candidates

In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.

Rates of Fatty Liver Disease Are Rising Worldwide

Men, people with obesity and people who smoke are more likely to develop NAFLD.

Lean People With NAFLD May Have Higher Risk of Death

Lean people had a higher mortality rate despite experiencing fewer metabolic problems.

Are you aware of non-alcoholic fatty liver disease (NAFLD/NASH)?

Clinical Trials

Caring for Someone With Liver Disease

Hot topics

illustration of colorful pills with smile and frown faces

NAFLD/NASH Medication Drug Chart

What are the symptoms of NAFLD/NASH?

Fatty Liver Disease Increases Among Americans

Obesity-linked liver disease has increased 131% in the past three decades.

Fecal Microbiota Transplant Improves Gut Health in People With Cirrhosis

Restoration of gut function and microbial diversity could lead to improvement of hepatic encephalopathy.

Resmetirom Improves NASH and Liver Fibrosis in Phase III Trial

The findings could potentially lead to the first FDA approval of a treatment for fatty liver disease.

Liver Cirrhosis and Related Mortality Are Projected to Rise

While hepatitis C remains a leading cause, cirrhosis is increasingly caused by fatty liver disease and alcohol use.

#fatty liver disease

Two Experimental Therapies Show Promise for NASH

11 Signs of Liver Disease

Regular Moderate Exercise Can Help Reduce Liver Fat

Two Experimental Therapies Show Promise for NASH

11 Signs of Liver Disease

Regular Moderate Exercise Can Help Reduce Liver Fat

NIH Awards $50.3 Million for “Multi-Omics” Research on Human Health and Disease

One Sugary Drink per Day May Increase Liver Cancer Risk in Women

Pecans May Help Prevent Fatty Liver Disease, Diabetes

Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?

People With NASH Fare Worse Than Those With Diabetes

NASH Is Major Cause of Liver Cancer Among Transplant Candidates

Rates of Fatty Liver Disease Are Rising Worldwide

Lean People With NAFLD May Have Higher Risk of Death

Are you aware of non-alcoholic fatty liver disease (NAFLD/NASH)?

Clinical Trials

Caring for Someone With Liver Disease

Hot topics

NAFLD/NASH Medication Drug Chart

What are the symptoms of NAFLD/NASH?

Fatty Liver Disease Increases Among Americans

Fecal Microbiota Transplant Improves Gut Health in People With Cirrhosis

Resmetirom Improves NASH and Liver Fibrosis in Phase III Trial

Liver Cirrhosis and Related Mortality Are Projected to Rise

Liver Basics

Science News

Features